What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.91%
Annual Rate
KRW 200.00Paid annual
Payout Ratio
26.6%Sustainable
Last Ex-Dividend
Mar 30, 2026
The reported statements, read against the company's own industry.
What stands out
Earnings significantly exceed cash generation
Financials view
Market Capitalization
459.12BKRW
331.17M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing P/E
34.71x
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Revenue (TTM)
141.29BKRW
101.92M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
9.95%
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Beta
1.70x
vs all stocks
Updated Sep 21, 2026
52-Week Change
-8.94%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
459.12BKRW
331.17M · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
431.79BKRW
311.46M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing P/E
34.71x
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
PEG Ratio
0.7028x
Updated Sep 21, 2026
Price to Sales (TTM)
3.29x
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Price to Book (MRQ)
1.48x
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Enterprise to Revenue
3.06x
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Enterprise to EBITDA
22.09x
vs Pollution & Treatment Controls peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 15.84×.Updated Sep 21, 2026
Gross Margin
26.99%
vs Pollution & Treatment Controls peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 30.07%.Updated Sep 21, 2026
Profit Margin
9.95%
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Operating Margin
14.51%
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Return on Assets (TTM)
1.87%
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Return on Equity (TTM)
4.69%
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Revenue (TTM)
141.29BKRW
101.92M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
6.75KKRWUpdated Sep 21, 2026
Quarterly Revenue Growth
0.70%
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Gross Profit (TTM)
42.48BKRW
30.64M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
27.25BKRW
19.66M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
14.06BKRW
10.14M · vs all stocks (USD)
Updated Sep 21, 2026
Quarterly Earnings Growth (YoY)
22.70%
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Operating Cash Flow (TTM)
-4.36BKRW
-3.14M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
-41.79BKRW
-30.14M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing Annual Dividend Rate
200.00KRWUpdated Sep 21, 2026
Trailing Annual Dividend Yield
0.91%
vs all stocks
Updated Sep 21, 2026
Payout Ratio
26.63%
vs Pollution & Treatment Controls peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 31.7%.Updated Sep 21, 2026
Revenue
141.06BKRWFY2025 · Dec 31, 2025
Cost of Goods Sold
99.36BKRWFY2025 · Dec 31, 2025
Gross Profit
41.70BKRWFY2025 · Dec 31, 2025
Operating Income
11.71BKRW
8.45M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
15.20BKRWFY2025 · Dec 31, 2025
Income Tax Expense
1.98BKRWFY2025 · Dec 31, 2025
Net Income
13.22BKRWFY2025 · Dec 31, 2025
EBIT
16.94BKRWFY2025 · Dec 31, 2025
EBITDA (Income Statement)
23.77BKRWFY2025 · Dec 31, 2025
Research & Development
13.10BKRWFY2025 · Dec 31, 2025
Selling, General & Administrative
6.93BKRWFY2025 · Dec 31, 2025
Other Operating Expenses
-184.41MKRWFY2025 · Dec 31, 2025
Non-operating Interest Income
3.07BKRWFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.73BKRWFY2025 · Dec 31, 2025
EPS (Basic)
631.00KRWFY2025 · Dec 31, 2025
EPS (Diluted)
631.00KRWFY2025 · Dec 31, 2025
Basic Shares Outstanding
20.95MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
20.95MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
13.22BKRWFY2025 · Dec 31, 2025
Operating Cash Flow
2.20BKRWFY2025 · Dec 31, 2025
Free Cash Flow
-33.20BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
153.38BKRWFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
13.22BKRWFY2025 · Dec 31, 2025
Stock-based Compensation
570.02MKRWFY2025 · Dec 31, 2025
Other Non-cash Items
-1.34BKRWFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
7.32BKRWFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-17.57BKRWFY2025 · Dec 31, 2025
Capital Expenditures
-35.40BKRWFY2025 · Dec 31, 2025
Net Acquisitions
-718.80MKRWFY2025 · Dec 31, 2025
Purchase of Investments
-448.71BKRWFY2025 · Dec 31, 2025
Sale of Investments
541.51BKRWFY2025 · Dec 31, 2025
Other Investing Activity
1.64BKRWFY2025 · Dec 31, 2025
Net Investing Cash Flow
58.32BKRWFY2025 · Dec 31, 2025
Long-term Debt Issuance
28.50BKRWFY2025 · Dec 31, 2025
Long-term Debt Payments
-68.00BKRWFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
3.00BKRWFY2025 · Dec 31, 2025
Common Dividends Paid
-6.28BKRWFY2025 · Dec 31, 2025
Other Financing Charges
575.18MKRWFY2025 · Dec 31, 2025
Net Financing Cash Flow
-42.20BKRWFY2025 · Dec 31, 2025
Shares Outstanding
20.96MSharesUpdated Sep 21, 2026
Float Shares
13.51MSharesUpdated Sep 21, 2026
% Held by Insiders
35.40%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
3.05%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
142.63BKRW
102.88M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
6.80KKRWUpdated Sep 21, 2026
Total Debt (MRQ)
109.01BKRW
78.63M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
0.3573x
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Current Ratio (MRQ)
3.09x
vs Pollution & Treatment Controls peers
Updated Sep 21, 2026
Book Value per Share (MRQ)
14.80KKRWUpdated Sep 21, 2026
Total Assets
458.92BKRW
331.03M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
280.22BKRWFY2025 · Dec 31, 2025
Total Liabilities
154.21BKRWFY2025 · Dec 31, 2025
Total Non-current Assets
178.70BKRWFY2025 · Dec 31, 2025
Total Non-current Liabilities
56.53BKRWFY2025 · Dec 31, 2025
Total Current Liabilities
97.69BKRWFY2025 · Dec 31, 2025
Cash Equivalents
153.38BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents
153.38BKRWFY2025 · Dec 31, 2025
Other Short-term Investments
8.21BKRWFY2025 · Dec 31, 2025
Accounts Receivable
20.46BKRWFY2025 · Dec 31, 2025
Inventory
19.03BKRWFY2025 · Dec 31, 2025
Accounts Payable
17.45BKRWFY2025 · Dec 31, 2025
Short-term Debt
61.19BKRWFY2025 · Dec 31, 2025
Other Current Liabilities
430.00KRWFY2025 · Dec 31, 2025
Long-term Debt
47.75BKRWFY2025 · Dec 31, 2025
Other Non-current Liabilities
10.00KRWFY2025 · Dec 31, 2025
Common Stock (Book)
10.49BKRWFY2025 · Dec 31, 2025
Retained Earnings
79.90BKRWFY2025 · Dec 31, 2025
Total Shareholders' Equity
304.71BKRW
219.79M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
543.45MKRWFY2025 · Dec 31, 2025
52-Week Low
20.00KKRWUpdated Sep 21, 2026
52-Week High
46.90KKRWUpdated Sep 21, 2026
52-Week Change
-8.94%
vs all stocks
Updated Sep 21, 2026
Beta
1.70x
vs all stocks
Updated Sep 21, 2026
50-Day MA
24.00KKRWUpdated Sep 21, 2026
200-Day MA
28.57KKRWUpdated Sep 21, 2026
Avg 10-Day Volume
91.82KSharesUpdated Sep 21, 2026
Avg 30-Day Volume
141.81KSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
631.00KRWUpdated Sep 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.